# Amphastar Pharmaceuticals, Inc. (AMPH) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Amphastar Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AMPH/mda/fy2025/): filed 2026-02-26; accession 0001297184-26-000009 (https://www.sec.gov/Archives/edgar/data/1297184/000129718426000009/amph-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/AMPH/mda/fy2024/): filed 2025-03-03; accession 0001297184-25-000008 (https://www.sec.gov/Archives/edgar/data/1297184/000129718425000008/amph-20241231x10k.htm)
- [FY 2023 MD&A](/company/AMPH/mda/fy2023/): filed 2024-02-29; accession 0001297184-24-000009 (https://www.sec.gov/Archives/edgar/data/1297184/000129718424000009/amph-20231231x10k.htm)
- [FY 2022 MD&A](/company/AMPH/mda/fy2022/): filed 2023-03-01; accession 0001297184-23-000019 (https://www.sec.gov/Archives/edgar/data/1297184/000129718423000019/amph-20221231x10k.htm)
- [FY 2021 MD&A](/company/AMPH/mda/fy2021/): filed 2022-03-11; accession 0001297184-22-000007 (https://www.sec.gov/Archives/edgar/data/1297184/000129718422000007/amph-20211231x10k.htm)

Back to /company/AMPH/